chrX-104250580-C-G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_StrongBP6BS2_Supporting
The NM_153448.4(ESX1):āc.869G>Cā(p.Arg290Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000625 in 1,151,565 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 24 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_153448.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ESX1 | NM_153448.4 | c.869G>C | p.Arg290Pro | missense_variant | 4/4 | ENST00000372588.4 | NP_703149.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ESX1 | ENST00000372588.4 | c.869G>C | p.Arg290Pro | missense_variant | 4/4 | 1 | NM_153448.4 | ENSP00000361669 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000121 AC: 11AN: 90724Hom.: 0 Cov.: 21 AF XY: 0.0000821 AC XY: 2AN XY: 24370
GnomAD3 exomes AF: 0.000149 AC: 22AN: 147967Hom.: 0 AF XY: 0.000111 AC XY: 5AN XY: 45189
GnomAD4 exome AF: 0.0000575 AC: 61AN: 1060799Hom.: 0 Cov.: 32 AF XY: 0.0000647 AC XY: 22AN XY: 340083
GnomAD4 genome AF: 0.000121 AC: 11AN: 90766Hom.: 0 Cov.: 21 AF XY: 0.0000819 AC XY: 2AN XY: 24406
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 13, 2023 | The c.869G>C (p.R290P) alteration is located in exon 4 (coding exon 4) of the ESX1 gene. This alteration results from a G to C substitution at nucleotide position 869, causing the arginine (R) at amino acid position 290 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Dec 01, 2023 | ESX1: BP4, BS2 - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at